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Portugal has one of the most severe HIV-1 epidemics in Western Europe. Two subtypes cir-
culate in parallel since the beginning of the epidemic. Comparing their transmission patterns
and its association with transmitted drug resistance (TDR) is important to pinpoint transmis-
sion hotspots and to develop evidence-based treatment guidelines.
Methods
Demographic, clinical and genomic data were collected from 3599 HIV-1 naive patients
between 2001 and 2014. Sequences obtained from drug resistance testing were used for
subtyping, TDR determination and transmission clusters (TC) analyses.
Results
In Portugal, transmission of subtype B was significantly associated with young males, while
transmission of subtype G was associated with older heterosexuals. In Portuguese origi-
nated people, there was a decreasing trend both for prevalence of subtype G and for num-
ber of TCs in this subtype. The active TCs that were identified (i.e. clusters originated after
2008) were associated with subtype B-infected males residing in Lisbon. TDR was signifi-
cantly different when comparing subtypes B (10.8% [9.5–12.2]) and G (7.6% [6.4–9.0]) (p =
0.001).
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L’’Oréal Portugal Medals of Honor for Women in
Discussion
TC analyses shows that, in Portugal, the subtype B epidemic is active and fueled by young
male patients residing in Lisbon, while transmission of subtype G is decreasing. Despite
similar treatment rates for both subtypes in Portugal, TDR is significantly different between
subtypes.
Introduction
Portugal had one of the highest rates of HIV diagnoses in Europe in 2016, with 10.0 diagnoses
per 100,000 population [1]. Despite the fact that new diagnoses have decreased within the
country in the last years [2], the patterns of HIV-1 transmission remain uncertain. Phyloge-
netic analyses are powerful tools to understand the dynamics of viral transmission [3–7] and
to provide insights for designing prevention policies.
According to the European and Portuguese guidelines for antiretroviral treatment [8,9], a
baseline resistance test should be performed to determine transmitted drug resistance (TDR),
which can impact the first-line antiretroviral response [10]. The last nationwide survey was
carried out in 2003 and showed 7.8% of TDR [11]. Surveillance of TDR is important for the
development of treatment guidelines, especially in Portugal where considerable migration
from Portuguese speaking countries occurs, including some African countries where the levels
of TDR are increasing along with the recent scaling-up of NRTI and NNRTI based treatments
[12,13].
The epidemiology of HIV-1 in Portugal is unique in comparison to other European coun-
tries. Most of the epidemic is caused by parallel sub-epidemics of subtype B and subtype G
[14]. Until 2005, subtype B accounted for approximately 40% of infections and subtype G
accounted for 30% [11,14,15]. The present large-scale cohort provides the unique opportunity
to compare the temporal evolution of the parallel epidemics of these subtypes in the same
country. Herein, we use transmission cluster reconstruction to understand the drivers of HIV-
1 transmission in Portugal and its correlation with primary drug resistance: prevalence of
TDR and factors associated with the spread of TDR. The characterization of HIV-1 transmis-
sion in the Portuguese epidemic can help to design targeted prevention strategies.
Patients and methods
Study population
The protocol was in accordance with the Declaration of Helsinki and approved by the Ethical
Committee of Centro Hospitalar de Lisboa Ocidental (108/CES-2014). The Portuguese HIV-1
drug resistance database contains retrospective anonymized patients’ information, including
demographic, clinical and genotype resistance testing data from patients followed up in 22
hospitals located around the country. All patients’ data collected from the RegaDB database
was generated during routine clinical care [16]. The inclusion criteria for the analysis of TDR
was age older than 18 years and no history of antiretroviral treatment between January 2001
and December 2014. This cohort is named PT-naive, hereafter. The genomic data included the
protease and the reverse transcriptase (HXB2: 2253–3554) obtained through population
sequencing using the ViroSeq assay.
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Drug resistance assessment
Surveillance drug resistance mutations (SDRM) were defined according to the WHO list [17].
The impact of TDR was evaluated with the HIVdb v.7.0 and Rega v.9.1.0 (http://sierra2.stanford.
edu/sierra/servlet/JSierra?action=algSequenceInput).
Subtyping and transmission cluster analyses
HIV-1 subtypes were determined with Rega v3 and COMET v.1.0 [18][19,20]. Subtype G and
CRF14_BG were merged in a single group (named hereafter G dataset), given that: i) this
genomic region has the same evolutionary origin for G and CRF14_BG strains; ii) the origin of
the CRF14_BG strains occurred in the Iberian Peninsula [14,19,21]; iii) previously, we
reported that the two tools and the manual phylogenetic analyses were not conclusive whether
the sequences were G or CRF14_BG in the present cohort [17]; iv) there was no recombination
breakpoint in the genomic regions of protease and reverse transcriptase in these sequences. A
statistical sub-analysis was performed considering only “pure" subtype G strains (excluding
CRF14_BG), defined by the concordant assignment of the two subtyping tools [19,20], to eval-
uate how this affected our findings (Tables C and D in S1 File).
For the TCs analysis, the dataset was complemented with controls retrieved from: (i) the
treated population of the Portuguese cohort between 2001 and 2014, (ii) the 50 best-matched
sequences to each sequence of the total cohort of subtype B and G, as retrieved by BLAST
(http://blast.ncbi.nlm.nih.gov/Blast.cgi), (iii) all HIV-1 pol subtype B and G sequences avail-
able from Portugal in the Los Alamos database (http://www.hiv.lanl.gov) [22]. Three subtype
D or B reference sequences were used as the outgroup. Sequences with low quality, duplicates
and clones were deleted. The resulting dataset was aligned with Muscle [23] and verified for
codon-correctness using VIRULIGN [24]. To avoid convergent evolution, SDRMs were
removed [17]. The final subtype B and G datasets consisted of 7497 and 4372 sequences, both
with a length of 1173 nucleotides (IQR:1173–1173).
A Maximum likelihood tree was constructed with the GTR+ 4Γ nucleotide substitution
model and 1000 bootstraps, as implemented in RAxML version 7.5.5. The transmission clus-
ters (TC) were identified with Cluster Picker using a threshold that included a genetic distance
of 0.045 and� 80% bootstrap replicates [5,25]. To evaluate the effect of the definition of TCs
in the results, sensitivity analyses were performed with varying genetic distances (0.015, 0.030,
0.045, 0.060) and bootstrap supports (70, 90, 95, 98).
TCs identified were confirmed with Bayesian Markov Chain Monte Carlo (MCMC) infer-
ence, as implemented in BEAST v1.8.2 [26]. The temporal signal of the TCs datasets was evalu-
ated with TempEst [27]. The uncorrelated log-normal relaxed molecular clock with a
discretized GTR substitution model and the Bayesian Skygrid coalescent model were used
[28]. Three separate MCMC chains were run for at least 100 million generations. Convergence
was determined with Tracer using a burn-in of 10% (http://beast.bio.ed.ac.uk/Tracer). The
maximum clade credibility (MCC) tree was constructed with TreeAnnotator after discarding
the burn-in, and visualized with FigTree v1.4.2 (http://tree.bio.ed.ac.uk).
The TCs analyses included the following definitions: (i) A pair was defined as exactly two
patients included in a TC, one of them from the PT-naive cohort; (ii) a cluster�3 included
three or more patients, with at least one from the PT-naive cohort (iii) a TDR-cluster-�3 or
TDR-pair contain at least one PT-naive patient with a sequence harboring a SDRM; (iv) an
onward-TDR-cluster had�3 patients with the same SDRM in the majority of the patients and
at least one from the PT-naive cohort with TDR, which suggest onward transmission of TDR;
and (v) active-TCs included transmission of HIV-1 or/and TDR that involves at least one PT-
naive patient within a time frame of�5 years. The time frame was calculated as the maximum
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length of time between the ancestral node and the most recent tip (year 2014) of the MCC trees
[29]. As such, a TC could be separated in two or more active sub-clusters, since such sub-clus-
ters may indicate the population which actively transmitted HIV-1 or TDR in the last years.
Statistical analyses
Statistical analyses were performed to understand and compare the dynamics of the subtype B
and G sub-epidemics in the PT-naive cohort, specifically the factors associated with transmis-
sion of HIV-1B and HIV-1G, independently of TDR; and the factors associated with transmis-
sion of TDR. All these analyses were performed within and compared between subtypes.
Sensitivity analyses (S1 File) were performed and, if a result was discordant in the sensitivity
analysis, the difference is clearly stated throughout the manuscript.
The Fisher’s exact test or regression techniques were conducted to compare between pro-
portions, while the Mann Whitney U test or the t-test were used to compare between median
or mean values for continuous variables, as appropriate. Binomial logistic regression was used
to determine the factors associated with each epidemic, TDR, and clustering. The Bonferroni
method was used for multiple testing adjustments. The level of statistical significance was set
at 5%. The analyses were performed with the statistical R software v.3.2.1.
Results
Study population
The PT-naive cohort included a total of 3599 patients, 2042 with subtype B (56.7%) and 1557
(43.3%) with G. The socio-demographic factors are shown in Tables A and B in S1 File.
Subtype B sub-epidemic is associated with young males living in Lisbon
Regarding the socio-demographic factors associated with the transmission of the sub-epidemic
B versus G in the PT-naive cohort, there were significant differences between the two sub-epi-
demics for age, gender, risk of transmission, residence in Lisbon, and CD4 count in the univar-
iate analyses, while in the multivariate analyses younger age (Odds Ratio (OR): 0.83 for every
increase of 10 years (10-years), 95% Confidence interval: 0.79–0.89, p<0.0001), male (OR: 2.66,
2.28–3.09, p<0.0001) and living in Lisbon (OR: 1.44, 1.25–1.66, p<0.0001) were significantly
associated with subtype B infections.
Transmission of subtype B is driven by young males
There were 497 TCs that included 61.2% of the subtype B PT-naive cohort (Table 1) When
comparing the cohort outside versus inside TCs of subtype B in the multivariate analysis, indi-
viduals inside subtype B TCs were younger (OR10-years: 0.83, 0.76–0.90, p<0.0001) and more
frequently male (OR 1.42, 1.14–1.78, p = 0.001) than individuals outside the TCs, indicating
that young males are driving this sub-epidemic in Portugal as we have identified in other Euro-
pean cohorts [5].
The number of PT-naive patients included in TCs had a peak in 1999 for clusters�3 fol-
lowed by a steady decrease, while the peak in the number of patients in pairs occurred in 2002
followed by an up and down curve (Fig 1A). This peak in 1999 includes 38% of the PT-naive
cohort, which suggests transmission of HIV was still ongoing for subtype B despite the intro-
duction of HAART.
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Transmission of subtype G is decreasing in native Portuguese people
There were 333 TCs that contained 46.6% of the G PT-naive cohort (Table 1 and Tables A and
B in S1 File). None of the socio-demographic or clinical factors were significantly associated
with transmission of subtype G. Interestingly, a decreasing trend in the percentage of native
Portuguese people included in TCs was observed since 2005 (p = 0.006, Fig 2A).
Table 1. Characteristics of the transmission clusters (TCs) in the general cohort and in the cohort with TDR.
Characteristic General population TDR population in TCs
B G p-value B G p-value
n % n % n % n %
Clusters
Number of cohort clusters 497 100 333 100 82 100 31 100
Median size (IRQ) 2 (2–3) 2 (2–3) NS 3 (2–4) 2 (2–4) NS
Number of Cluster�3 221 44.5 132 39.6 NS 42 51.2 15 48.4 NS
Median size (IRQ) 4 (3–5) 4 (3–5) NS 4 (3–6) 4 (3–6) NS
Number of active clusters 120 24.1 47 14.1 0.0003 26 31.7 4 12.9 NS
Median size (IRQ) 2 (2–3) 2 (2–2) NS 2 (2–3) 2,5 (2–3) NS
Number of Cluster�3 36 7.2 4 1.2 <0.0001 11 13.4 2 6.5 NS
Median size (IRQ) 3 (3–4) 3 (3–3.25) NS 3 (3–4) 3 (-)
Number of clusters that suggests onward TDR
Number of Cluster 24 29.3 7 22.6 NS
Median size (IRQ) - - - - 3 (3–4) 4 (3–5) NS
Still active 7 8.5 1 3.2 NS
Median size (IRQ) - - - - 2 (2–2.5) 3 (-)
Patients
Number in cohort clusters
Number of cohort and controls 1636 100 972 100 343 100 100 100
Number of cohort patients 1250 100 726 100 NS 146 100 51 100 NS
Cluster�3
Number of cohort and controls 1084 66.3 570 58.6 0.0001 263 76.7 68 68 NS
Number of cohort patients 828 66.2 411 56.6 <0.0001 99 67.8 30 58.8 NS
Number in active clusters
Number of cohort and controls 302 18.5 99 10.2 <0.0001 75 21.9 10 10.0 0.0089
Number of cohort patients 286 22.9 93 12.8 <0.0001 40 27.4 4 7.8 0.0225
Cluster�3
Number of cohort and controls 134 8.2 12 1.2 <0.0001 43 12.5 6 6.0 NS
Number of cohort patients 128 10.2 12 1.7 <0.0001 19 13.0 1 2.0 N
Number in clusters that suggests onward TDR
Cluster�3
Number of cohort and controls - - - - - 95 27.7 32 32.0 NS
Number of cohort patients - - - - - 72 49.3 21 41.2 NS
Still active - - - - -
Number or cohort and controls - - - - - 26 7.6 6 6.0 NS
Number of cohort patients - - - - - 26 17.8 2 3.9 NS
Abbreviations: IQR: interquartile range, n: sample, NS: No significant, TCs: Transmission clusters TDR: transmitted drug resistance, % percentage.
https://doi.org/10.1371/journal.pone.0218226.t001
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The numbers of PT-naive patients included in TCs had an up and down curve, as
clusters� 3 originated more frequently in 2001 followed by a steady decrease, while this peak
Fig 1. Number of naïve patients in transmission clusters of the PT-naïve cohort vs time of origin (i.e. most recent common ancestor- MRCA) of those TCs. The
number of naive patients included in the TCs is represented in the y-axis while the year of origin is in the x-axis. The type of clusters is presented as pairs (dashed line) and
clusters�3 (solid line) for B (dark red) and G-like (blue). (A) Time of origin (MRCA) of non-drug resistant TCs in the PT-naïve cohort (B) Time of origin (MRCA) of all
TDR TCs in the PT-naïve cohort. Time of introduction of Highly Effective Antiretroviral Therapy (HAART) (1996), time of start of needle and syringe program (NSP) in
Portugal (1993), time of increasing number of regimen options (2001) and time of introduction of potent drugs (2007) are marked as grey dotted lines in the x-axis.
https://doi.org/10.1371/journal.pone.0218226.g001
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occurred in 2005 for pairs (Fig 1A). In contrast with subtype B, most PT-naive patients were
involved in TCs originated before the introduction of HAART; i.e. G: 45 TCs included 266
patients (17.1%) vs B: 63 TCs with 114 patients (9%); (p<0.0001).
In the last years, subtype B transmission was predominant and occurred
between patients sampled in Portugal
In a sub-analysis considering only TCs originating in the last five years of the cohort (active-
TCs), 24.1% (120/497) and 14.1% (47/333) TCs were subdivided in smaller active-TCs for sub-
type B and G, respectively (Table 1). These active-TCs included mainly subtype B patients
(75.5%, 286/379 compared to 23.9% (93/379) for subtype G (p<0.0001)). Socio-demographic
Fig 2. Prevalence of subtype G in Portuguese originated people during the period of the study (years in the y-axis)
when considering the ones who were in transmission clusters (A). The light blue shades are the confidence intervals of
the proportion of patients for a period of two years (dark blue line). The first period was excluded given the few
numbers of patients but significance did not change. (B) Prevalence (dot) and 95% confidence intervals of the
Transmitted drug resistance for subtypes B (red) and G (dark blue) for the PT-naive cohort and for each drug group.
Geographical differences were observed for TDR when Lisbon was compared with other regions. Significant
differences are shown with an asterisk. Abbreviations: NRTI: Nucleoside reverse transcriptase inhibitors, NNRTI: non-
NRTI, PI: Protease inhibitors; TCs: Transmission clusters, vs: versus, %: percentage.
https://doi.org/10.1371/journal.pone.0218226.g002
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characteristics of the patients in active-TCs and the total cohort were similar (Tables A and B
in S1 File). Males (OR: 6.56, 3.63–11.85, p<0.0001) and patients living in Lisbon (OR: 2.03,
1.12–3.69, p<0.05) were associated with the active transmission of subtype B when compared
with G. Since we completed our cohort with controls retrieved from other databases, it is
important to note the active-TCs included mainly controls sampled in Portugal for both sub-
types, indicating transmission of HIV-1 predominantly occurs between patients in Portugal.
TDR in subtype G occurs more frequently in patients followed-up in
hospitals outside the Lisbon area
In the subtype B PT-naive cohort, the prevalence of TDR was 10.8% [221/2042; 9.5–12.2%],
4.9% [102/2042; 4.1–6.0] for nucleoside reverse transcriptase inhibitors (NRTIs), 4.7% [96/
2042; 3.8–5.7%] for Non-NRTIs (NNRTIs) and 3.9% [80/2042; 3.1–4.8] for protease inhibitors
(PIs) (Fig 2B). Dual class resistance was found in 19.5% and triple class was found in 3.2% of
subtype B patients. Regarding the socio-economical and clinical factors, none of the factors
were associated with TDR in the multivariate analysis for this subtype.
For subtype G, the TDR prevalence in the PT-naive cohort was 7.6% [118/1557, 6.4–9.0],
1.7% [27/1557; 1.2–2.5] for NRTIs, 4.9% [76/1557; 3.9–6.0] for NNRTIs and 2.2% [34/1557;
1.6–3.0] for PIs. Dual and triple class resistance were found, respectively, in 12.7% and 1.7% of
subtypes G patients. Older age, heterosexual transmission and living outside of Lisboa and
Vale do Tejo regions were significantly associated with TDR in subtype G (Fig 2B). The multi-
variate analysis showed people living outside of the Lisboa and Vale do Tejo regions associated
with TDR in subtype G (OR: 1.87, 1.22–2.88).
When subtype B and G were compared, there were higher prevalence of TDR (OR: 1.47,
1.17–1.89, p = 0.001), NRTIs TDR (OR: 2.98, 1.92–4.76, p<0.0001) and PIs TDR (OR: 1.83,
1.20–3.83, p = 0.003) for subtype B. Subtype B patients with TDR were also older (OR10-years:
0.68, 0.55–0.82, p = 0.001) and more frequently male (OR: 3.10, 1.83–5.24, p<0.0001).
Active and onward transmission of TDR for subtype B is driven by males
living in Lisbon
Eighty-two subtype B TCs had at least one patient from the PT-naive cohort harboring viruses
with SDRMs (TDR-TCs, Table 1). The TDR-TCs included 66.1% (n = 146/221) of the total num-
ber of patients with TDR compared to 43.2% for G (n = 51/118; p<0.0001; Table A in S1 File),
indicating more active transmission of TDR in subtype B. When the Portuguese treated popula-
tion was included as complementary database for the TCs analyses, it was observed that nearly
half (n = 39/82) of the TDR-TCs for subtype B included at least one treated patient. However, the
number of treated patients in subtype B TDR-TCs decreased over time since 2006 (p<0.0001).
The origin of subtype B TDR-TCs was mainly between 1999 and 2005: 23 pairs and 26 clus-
ters�3 represented 60% (n = 88/146) of the PT-naive cohort in clusters harbouring viruses
with SDRMs (Fig 1B). There were no socio-demographic factors associated with the transmis-
sion of SDRMs for subtype B.
Twenty-six TDR-TCs originated in the last five years for subtype B (active clusters; Table 1
and Table A in S1 File). This population was similar to the population involved in subtype B
active clusters: male (85%, 64/75), living in Lisboa and Vale do Tejo region and<35 years old
(both 65.3%). Twenty-four TDR-TCs had evidence of onward transmission of SDRMs, those
were mainly thymidine analog mutations (TAMs) and/or NNRTIs SDRMs. Seven out of those
24 TDR-TCs with evidence of onward transmission were still active in the last five years. The
characteristics of the population reflected that male (77%, 20/26) and living Lisboa and Vale do
Tejo region (69.2%) still drive the transmission of TDR.
Drivers of HIV-1 transmission in Portugal
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As expected, when transmission of TDR was compared in the subtype B and G sub-epidem-
ics, subtype B was significantly associated with transmission of TDR (OR: 1.75, 1.24–2.49,
p = 0.0007). In this subtype, younger age (OR10-years: 0.53, 0.39–0.73, p<0.0001) and males
(OR: 4.53, 1.92–10.66 p = 0.0005) were consistently associated with transmission of TDR.
The onward and active transmission of TDR for subtype G is limited
Thirty-one subtype G TDR-TCs included 43.2% (51/118) patients from the PT-naive cohort
harbouring viruses with SDRMs (Table 1 and Table B in S1 File). Nearly half (n = 15/31) of the
TDR-TCs for subtype G included at least one treated patient.
When considering the time origin of TDR-TCs, 35.3% patients of the PT-naive cohort were
involved in TDR-TCs originated between 1996 and 1999, followed by 27.5% between 2000–
2003 (Fig 1B). Then, mainly pairs including 27.5% and 25.5% of the TDR-patients were origi-
nated in 2000–2003 and 2004–2008, respectively. There were no socio-demographic factors or
time trends associated with transmission of TDR. When including controls and comparing
people transmitting TDR versus without TDR in TCs of subtype G, age (median: 44, IQR: 34–
54 versus 37, 31–46, p = 0.002), and viral load were significant in the univariate analysis
(median: 4.9 Log-copies/mm3, IQR: 4.4–5.7 versus 4.6, 3.9–5.2, p = 0.03). However, those were
no longer significant in the multivariate analyses. When TDR-TCs�3 were analysed including
controls, residence outside of the Lisboa and Vale do Tejo region was significantly associated
with TDR within subtype G in the multivariate analysis (OR: 2.96, 1.29–6.79, p = 0.01). Inter-
estingly, this geographical pattern was no longer observed in the seven onward-TDR clusters,
and from those only one was an active-TC. Unlike subtype B, the socio-demographic factors
did not show any clear pattern.
Discussion
Transmission cluster reconstruction has been previously used to understand HIV-1 and resis-
tance transmission patterns in other settings [3–7]. Herein, we combine and compare the
information provided by classical statistical analyses of the most complete Portuguese cohort
available, stratified by subtypes, with the one retrieved from transmission clusters analyses.
Through our detailed analyses of the Portuguese HIV-1 epidemic, we find strong indica-
tions that: 1) transmission of subtype B is associated with younger males; 2) transmission of
subtype G is decreasing in Portugal and in the native Portuguese population; 3) transmission
of drug resistance has different patterns: males living in Lisboa and Vale do Tejo regions drive
the active and onward transmission of TDR, while this transmission is limited for subtype G
and does not correlate with any socio-demographic factors.
Importantly, active transmission of subtype B in the last years has been driven by males
residing in Lisbon. Although a source of uncertainty is the lack of risk factor information for a
large part of our cohort, the consistency of our findings in different analyses suggest an impor-
tant role of MSM living in Lisbon for this sub-epidemic. These results are consistent with
other studies in Europe, Brazil or USA, where young MSMs have been identified as the main
drivers of subtype B and TDR transmission [3–5,7]. More studies are needed to evaluate how
tourism or migration may influence these results.
We observed a decline both in the prevalence and in the number of patients present in sub-
type G TCs in native Portuguese people since 2005 (Fig 2A). This indicates that transmission of
subtype G strains is decreasing and that transmission has been limited in the last years. This sub-
epidemic was unique in Europe and mainly circulating within Portugal. It was imported from
West Africa, it was associated with intravenous drug users (IDUs) [30] and afterwards became
also prevalent in heterosexuals. With the introduction of the needle and syringe program in
Drivers of HIV-1 transmission in Portugal
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1993, new infections in IDUs declined and this could be potentially associated with the decrease
of viral transmission together with the introduction of HAART in 1996 [2,31]. This finding cor-
roborates how a long-term effective prevention program impacted HIV-1 transmission.
While we described that TDR levels differ between subtypes, with higher levels for B, the
overall TDR remains stable across time, which agrees with the European study SPREAD [32].
TC analyses indicates that onward transmission of TDR is limited and mainly associated with
subtype B and with a decreasing proportion of involvement of treated population since 2006. A
higher TDR level for subtype B for NRTIs and PIs could result from several factors: i) The earlier
beginning of the treatment for subtype B patients than for subtype G, and/or ii) a lower fitness
of G strains in presence of SDRMs, which would cause faster reversion and consequent lower
transmissibility level of SDRMs; and/or iii) behavioral patterns affecting the G sub-epidemic
dynamics, with slower transmission rates and therefore higher likelihood that SDRM revert
before their onward transmission; and/or iv) different treatment strategies for each subtype,
which is unlikely because these patients are treated in the same country with similar regimens.
Our results should be interpreted with caution due to the lack of information about the
time of infection, risk of transmission, country of origin and limited representativeness for the
North region of Portugal [2]. The BEST-HOPE project is prospectively collecting recent socio-
demographic and behavioral data to complete the picture of the current patterns of transmis-
sion in the country [33]. Finally, phylogenetic analyses have intrinsic limitations since it does
not provide information about sexual networks and depends on the sampling density [34].
In conclusion, we have shown different patterns of transmission of HIV-1 and resistance
for the two most important sub-epidemics in Portugal: subtype B and G. Our findings suggest
that long-term prevention policies have impacted the transmission of subtype G in Portugal
and resulted in decrease of prevalence of this subtype, while subtype B is reflecting the current
patterns of HIV-1 transmission that is happening in other European countries.
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given the amount of missing data. Abbreviations: IQR: interquartile range, n: sample, TDR:
transmitted drug resistance, % percentage.
Table C: Characteristics of the “pure” subtype G population in the PT-naive cohort between
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25. Ragonnet-Cronin M, Hodcroft E, Hué S, Fearnhill E, Delpech V, Brown AJL, et al. Automated analysis
of phylogenetic clusters. BMC Bioinformatics. 2013; 14: 317. https://doi.org/10.1186/1471-2105-14-317
PMID: 24191891
26. Drummond AJ, Suchard MA, Xie D, Rambaut A. Bayesian phylogenetics with BEAUti and the BEAST
1.7. Mol Biol Evol. 2012; 29: 1969–1973. https://doi.org/10.1093/molbev/mss075 PMID: 22367748
27. Rambaut A, Lam TT, Max Carvalho L, Pybus OG. Exploring the temporal structure of heterochronous
sequences using TempEst (formerly Path-O-Gen). Virus Evol. 2016; 2: vew007. https://doi.org/10.
1093/ve/vew007 PMID: 27774300
28. Gill MS, Lemey P, Faria NR, Rambaut A, Shapiro B, Suchard MA. Improving Bayesian population
dynamics inference: a coalescent-based model for multiple loci. Mol Biol Evol. 2013; 30: 713–724.
https://doi.org/10.1093/molbev/mss265 PMID: 23180580
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